Repare Therapeutics Inc. 4 SEC Filings

Filed On	Filing
30 Jan 2026	Form 4: Bvf Partners L P/IL, 10% owner and 9 others Disposed of 10,166,943 shares (Tender Offer)
28 Jan 2026	Form 4: Civik Thomas, Director Returned 7,500 shares to the issuer
28 Jan 2026	Form 4: Forte Steve, EVP, CHIEF FINANCIAL OFFICER Returned 56,786 shares to the issuer · Disposed of 1,110,800 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Jan 2026	Form 4: Alves Sandra Isabelle Barros, SVP, Finance and CAO Returned 31,622 shares to the issuer · Disposed of 50,500 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Jan 2026	Form 4: Schafer Carol, Director Returned 8,000 shares to the issuer · Disposed of 37,941 Stock Option (right to buy) (Disposition to Issuer)
28 Jan 2026	Form 4: Rhoads Ann D, Director Returned 4,000 shares to the issuer
29 Apr 2025	Form 4: Alves Sandra Isabelle Barros, SVP, Finance and CAO Received 4,100 shares as a grant or award · Granted 24,500 Employee Stock Option (right to buy)
04 Apr 2025	Form 4: Forte Steve, EVP, CHIEF FINANCIAL OFFICER Granted 500,000 Employee Stock Option (right to buy)
14 Mar 2025	Form 4: Koehler Maria, EVP, CHIEF MEDICAL OFFICER Sold 3,596 shares ($4.1K)
14 Mar 2025	Form 4: Zinda Michael, EVP, CHIEF SCIENTIFIC OFFICER Sold 5,611 shares ($6.4K)
14 Mar 2025	Form 4: Forte Steve, EVP, CHIEF FINANCIAL OFFICER Sold 6,884 shares ($7.85K)
14 Mar 2025	Form 4: Segal Lloyd Mitchell, Director Sold 21,179 shares ($24.1K)
06 Mar 2025	Form 4: Segal Lloyd Mitchell, Director Received 40,000 shares as a grant or award · Granted 237,000 Employee Stock Option (right to buy)
06 Mar 2025	Form 4: Zinda Michael, EVP, CHIEF SCIENTIFIC OFFICER Received 14,000 shares as a grant or award · Granted 160,000 Employee Stock Option (right to buy)
06 Mar 2025	Form 4: Forte Steve, EVP, CHIEF FINANCIAL OFFICER Received 14,000 shares as a grant or award · Granted 285,000 Employee Stock Option (right to buy)
20 Jun 2024	Form 4: Schafer Carol, Director Granted 27,200 Stock Option (right to buy)
20 Jun 2024	Form 4: Rhoads Ann D, Director Granted 27,200 Stock Option (right to buy)
20 Jun 2024	Form 4: Morrison Briggs, Director Granted 27,200 Stock Option (right to buy)
20 Jun 2024	Form 4: Molineaux Susan, Director Granted 27,200 Stock Option (right to buy)
20 Jun 2024	Form 4: Kulkarni Samarth, Director Granted 27,200 Stock Option (right to buy)

Comments